BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| Kojibiose | Kojibiose, a remarkable biomedicine, stands as a powerful solution for an array of dermatological afflictions. Renowned for its profound capacity to impede tyrosinase activity, this therapeutic wonder effectively combats skin pigmentation maladies like melasma and hyperpigmentation. Synonyms: 2-O-(a-D-Glucopyranosyl)-a-D-glucopyranose; Glc-a-1,2-Glc; D-Glucose, 2-O-α-D-glucopyranosyl-; 2-O-α-D-Glucopyranosyl-D-glucose. Grades: ≥95%. CAS No. 2140-29-6. Molecular formula: C12H22O11. Mole weight: 342.30. |  |
| Kojipentaose | Kojipentaose is an innovative compound product utilized in the research of hyperpigmentation and skin disorders. Derived from Kojic acid, this compound inhibits tyrosinase activity, reducing melanin production. CAS No. 112289-20-0. Molecular formula: C30H52O26. Mole weight: 828.72. | |
| Kojitetraose | Kojitetraose is an innovative compound, unveiling its immense potential in cardiac researchs. Hailing from natural origins, this remarkable molecule gracefully manifests profound antioxidant capabilities, defying oxidative onslaughts. With its anti-inflammatory demeanor, it diligently studys inflammation. Synonyms: Glca2Glca2Glca2Glc. CAS No. 112302-52-0. Molecular formula: C24H42O21. Mole weight: 666.58. | |
| Kojitriose | Kojitriose is an intricate trisaccharide compound, extensively employed within the biomedical sphere due to its underlying propensities for studying obesity, metabolic disorders and concomitant cardiovascular complications. CAS No. 74738-47-9. Molecular formula: C18H32O16. Mole weight: 504.44. | |
| Kotalanol | Kotalanol is a remarkable and highly specialized inhibitor, finding extensive application in the biomedical field for effectively studying diabetes and obesity. Its chief objective lies in skillfully targeting and effectively suppressing α-glucosidase is a pivotal enzyme crucial in the intricate domain of carbohydrate metabolism. It has the potent capability to inhibit α-glucosidase. Synonyms: 1,4-Dideoxy-1,4-[(S)-[7-deoxy-5-O-sulfo-D-glycero-D-galacto-heptitol-7-yl]episulfoniumylidene]-D-arabinitol inner salt. CAS No. 214491-07-3. Molecular formula: C12H24O12S2. Mole weight: 424.44. | |
| LacDiNAc dimer ethylazide | LacDiNAc dimer ethylazide is a biomedical product used in the research of certain diseases or conditions related to carbohydrate recognition. It acts as a specific and potent inhibitor for various carbohydrate-binding proteins. Its structure and activity can be explored further at the provided websites, enabling potential therapeutic applications in drug discovery and development within the biomedical industry. Synonyms: GalNAcb(1-4)GlcNAcb(1-3)GalNAcb(1-4)GlcNAc-b-ethylazide. Molecular formula: C34H57N7O21. Mole weight: 899.85. | |
| Lactitol anhydrous | Lactitol is used as a non-cariogenic substitute for sucrose, as a diluent in solid dosage forms and as a treatment for hepatic encephalopathy and as a laxative. Synonyms: 4-O-(b-D-Galactopyranosyl)-D-glucitol; 4-O-β-D-Galactopyranosyl-D-glucitol; D-4-O-β-D-Galactopyranosyl-glucitol; D-Lactitol; Finlac DC; Importal; Lactiobiosit; Lactit; Lactit M; Lactite; Lactosit; Lactositol; Lacty; Lacty-Tab; Milchen; Miruhen; NSC 231323. Grades: ≥97%. CAS No. 585-86-4. Molecular formula: C12H24O11. Mole weight: 344.31. | |
| Lactitol monohydrate | Lactitol monohydrate is an analogue of disaccharide lactulose. lt is used as replacement sweeteners and has been used in the treatment of constipation & hepatic encephalopathy. Uses: Lactitol monohydrate is used as replacement sweeteners and has been used in the treatment of constipation & hepatic encephalopathy. Synonyms: 4-O-(b-D-Galactopyranosyl)-D-glucitol monohydrate; 4-O-β-D-Galactopyranosyl-D-glucitol Monohydrate; Exportal. Grades: >98%. CAS No. 81025-04-9. Molecular formula: C12H24O11.H2O. Mole weight: 362.33. | |
| Lactobionate hydrazide | | |
| Lactobionic acid ethyl ester | | |
| Lactodifucotetraose | Lactodifucotetraose is a notable bioactive compound, emerging as a promising compound in studying ailments concerning the gastrointestinal realm. Its innate potential lies in fostering the proliferation of symbiotic gut microflora and catalyzing the intricate process of digestive assimilation. By virtue of its robust prebiotic attributes, Lactodifucotetraose efficaciously propels the state of gut well-being through studying inflammatory responses and fortifying the resilience of the immune system. Synonyms: LDFT; Difucosyl lactose. CAS No. 20768-11-0. Molecular formula: C24H42O19. Mole weight: 634.58. | |
| Lacto-N-biose | It is the receptor of helicobacter pylori α1,2-Focusyltransferase enzyme. Synonyms: Galβ1-3GlcNAc; Gal-b-1,3-GlcNAc; 2-Acetamido-2-deoxy-3-O-(b-D-galactopyranosyl)-D-glucopyranose; beta-D-galactsyl-(1->3)-N-acetyl-D-glucosamine; beta-D-Galactopyranosyl-(1->3)-N-acetyl-D-glucosamine; O-β-D-Galactopyranosyl-(1-3)-N-acetylglucosamine; Lewis C. Grades: ≥95%. CAS No. 50787-09-2. Molecular formula: C14H25NO11. Mole weight: 383.35. | |
| Lacto-N-difucohexaose I | Lacto-N-difucohexaose I is an indispensable compound in the biomedical field, exhibiting remarkable immunomodulatory attributes. Its application predominantly encompasses the research of multifarious ailments, encompassing particular cancer types and autoimmune afflictions. As a propitious research, this product adeptly modulates the immune response, potentially augmenting patient outcomes with unprecedented efficacy. Synonyms: LNDFH I; Lewisb antigen; 6-Deoxy-α-L-galactopyranosyl-(1->4)-[6-deoxy-α-L-galactopyranosyl-(1->2)-β-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-D-glucose; α-L-Fuc-(1-2)-β-D-Gal-(1-3)[α-L-Fuc-(1-4)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc. Grades: ≥95%. CAS No. 16789-38-1. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-difucohexaose I-APD-HSA | | |
| Lacto-N-difucohexaose I-APD-KLH | | |
| Lacto-N-difucohexaose I-BSA | | |
| Lacto-N-difucohexaose I-BSA (LNDFH I-BSA) (3 atom spacer) | It is a lewisb antigen linked to lactose spacer, a structure recognized by Helicobacter pylori that binds to human gastric epithelium. | |
| Lacto-N-difucohexaose II | Lacto-N-difucohexaose II, a carbohydrate compound prevalent in the biomedical industry for research purposes, has been found to impede pathogen adhesion to human intestinal cells. This realization has spurred speculation on the potential of Lacto-N-difucohexaose II as a viable candidate in the development of drug interventions for infectious maladies afflicting the gut. Equally exciting, Lacto-N-difucohexaose II may also offer promise as a cancer treatment. Synonyms: LNDFH II; Lewis A hexaose; D-Glucose, O-6-deoxy-alpha-L-galactopyranosyl-(1-3)-O-(O-6-deoxy-alpha-L-galactopyranosyl-(1-4)-O-(beta-D-galactopyranosyl-(1-3))-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-3)-beta-D-galactopyranosyl-(1-4))-; β-D-Gal-(1-3)-[α-L-Fuc-(1-4)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-D-Glc. Grades: ≥95%. CAS No. 62258-12-2. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-difucohexaose IV | Lacto-N-difucohexaose IV, recognized as a pivotal compound constituent, presents itself as a prospective remedial aide for an array of ailments like bacterial and viral infections. By focusing on distinct receptors and impeding the proliferation of malevolent microorganisms, this indispensable compound extensively contributes to the research of pathogenic infections. Its exceptional efficacy renders it an invaluable compound for biomedical drug advancement. Synonyms: LNDFH IV. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-difucopentaose I | Cas No. 221224-60-8. | |
| Lacto-N-fucopentaose I | Lacto-N-fucopentaose I (LNFPI) is a human milk oligosaccharide (HMO), possessing antiviral and antibacterial activity. Lacto-N-fucopentaose I can reduce capsid protein VP1 to block virus adsorption, promote CDK2 and reduce cyclin E to recover cell cycle S phase block. Lacto-N-fucopentaose I inhibits ROS production and Apoptosis in virus-infected cells. Lacto-N-fucopentaose I can also regulate intestinal microbiota to affect immune system development. Synonyms: LNFP I; Fuc-a-1,2-Gal-b-1,3-GlcNAc-b-1,3-Gal-b-1,4-Glc; Blood group O(H) type I determinant; α-l-fuc(1?2)-β-d-gal-(1?3)-β-d-glcnac-(1?3)-β-d-gal-(1?4)-d-glc; 6-Desoxy-α-L-galactopyranosyl-(1->2)-β-D-galactopyranosyl-(1->3)-2-acetamido-2-desoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-D-glucose. Grades: ≥95%. CAS No. 7578-25-8. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose I-biotin | Lacto-N-fucopentaose I-biotin - a bio-reagent in the biomedical industry. It helps researchers detect and analyze fucosylated oligosaccharides. Its biotin modification provides tactical binding options, leading to a better understanding of fucosylation events in biological processes such as pathogen binding, cancer development, and more. Molecular formula: C48H82N6O27S. Mole weight: 1207.26. | |
| Lacto-N-fucopentaose I-BSA | | |
| Lacto-N-fucopentaose I-BSA (LNFP I-BSA) (3 atom spacer) | Lacto-N-fucopentaose I-BSA (LNFP I-BSA) (3 atom spacer) is an instrumental biomedical tool employed to unravel the intricate molecular interplay between proteins and carbohydrates. This glycoprotein conjugate harbors the enigmatic Lacto-N-fucopentaose I, a sui generis complex carbohydrate that adorns cell surfaces and resides in body fluids. The product's salience lies in its ability to diagnose and treat a plethora of ailments including cancers, infections, and inflammation. | |
| Lacto-N-fucopentaose II | It is a human milk oilgosaccharide that can be associated with some gastrointestinal tumors. Synonyms: LNFP II; Lewisa antigen; Lewis A antigen; b-D-Gal-(1?3)-(a-L-Fuc-[1?4])-b-D-GlcNAc-(1?3)-b-D-Gal-(1?4)-D-Glc; β-D-Galp-(1?3)-[α-L-Fucp-(1?4)]-β-D-GlcpNAc-(1?3)-β-D-Galp-(1?4)-D-Glcp; Lewis-a pentasaccharide; LNF II; Lacto-N-fucopentaose-2; Lea penta. Grades: ≥95%. CAS No. 21973-23-9. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose II-APD-HSA | | |
| Lacto-N-fucopentaose II-APD-KLH | Lacto-N-fucopentaose II-APD-KLH is an extraordinary bioactive compound prevalent in the biomedical sector, exhibitionizes immense promise for research across diverse diseases through its remarkable affinities for selective receptors, namely Fucosyltransferase and Galectins. It has garnered extensive utilization within research domains aiming to unravel the intricacies of cancer, inflammation and immune-related maladies, as well as devising innovative strategies for their effective research. | |
| Lacto-N-fucopentaose II-BSA | | |
| Lacto-N-fucopentaose II-BSA (LNFP II-BSA) (3 atom spacer) | Lacto-N-fucopentaose II-BSA (LNFP II-BSA) (3 atom spacer), a biomedicine product designed for unravelling the mysteries of glycan-protein interactions. Widely employed for diagnosis of Helicobacter pylori (H. pylori) in serum samples of infected individuals, its applications extend beyond the laboratory. Studies have revealed its crucial role in illuminating the intricacies of carbohydrate-mediated ailments such as cancer and inflammation. | |
| Lacto-N-fucopentaose II-GEL | Lacto-N-fucopentaose II-GEL is a paramount biomedical compound, serving as a tool for deciphering intricate complexities attributed to the functions and interplays of carbohydrates within cellular systems. By facilitating the detection of lectins, glycosylation analysis and exploration of carbohydrate impacts on disease advancement, this product assumes a pivotal significance. Its indispensability lies in unraveling the pathogenesis of specific ailments and forging prospects for prospective researchs. | |
| Lacto-N-fucopentaose III | It is a human milk oilgosaccharide that can inhibit the adherence of pathogens to the intestinal epithelium. Synonyms: LNFP III; Lewis X antigen; Gal-b-1,4-(Fuc-a-1,3)-GlcNAc-b-1,3-D-Gal-b-1,4-Glc; Lex-lactosel; Lewis-X pentasaccharide; β-D-Galp-(1?4)-[α-L-Fucp-(1?3)]-β-D-GlcpNAc-(1?3)-β-D-Galp-(1?4)-D-Glcp; O-6-deoxy-alpha-L-galactopyranosyl-(1->3)-O-[beta-D-galactopyranosyl-(1->4)]-O-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-D-Glucopyranose; 6-Deoxy-α-L-galactopyranosyl-(1->3)-[β-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-D-glucose; Lacto-N-neofucopentaose II. Grades: ≥95%. CAS No. 25541-09-7. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose III-APD-HSA | | |
| Lacto-N-fucopentaose III-BSA | | |
| Lacto-N-fucopentaose III-BSA (LNFP III-BSA) (3 atom spacer) | Lacto-N-fucopentaose III-BSA (LNFP III-BSA) (3 atom spacer) is an astounding specialized biomedical wonder, harbors immense value for the scientific realm. This groundbreaking product unravels the intricacies behind carbohydrate-protein interactions, facilitating a comprehensive understanding of this enigmatic domain. A conjugate brimming with potential, LNFP III-BSA amalgamates the captivating carbohydrate structure of Lacto-N-fucopentaose III with the mighty Bovine Serum Albumin (BSA) and an elegant 3 atom spacer. Its importance transcends mere investigation, offering invaluable insights into drug development and the intricate pathology of diseases intricately linked to carbohydrate recognition. Prepare to embark on an academic odyssey like no other, courtesy of LNFP III-BSA. | |
| Lacto-N-fucopentaose III-GEL | Lacto-N-fucopentaose III-GEL is an advanced biomedical product engineered to precisely target and study diverse malignancies, including breast, ovarian and colon cancers. This exceptional gel conjugate seamlessly integrates the distinctive attributes of Lacto-N-fucopentaose III is a specific carbohydrate molecule, with a sophisticated gel matrix, thereby ensuring optimal drug administration and localized research. Through its selective adherence to cancerous cells, this compound holds remarkable prospects for individualized therapy, ultimately enhancing patient prognosis substantially. | |
| Lacto-N-fucopentaose VI | Lacto-N-fucopentaose VI is an esteemed biomedical compound, standing tall as a prodigious therapeutic ally in studying multifarious ailments. Abounding in cascading units of fucose and lactosamine, this exquisite glycan has sparked rapt attention. Careful scrutiny has unveiled its prodigious potentialities in revolutionizing the domain of cancer inhibition, inflammation mitigation and bacterial afflictions. Delve deeper into its astounding architecture and intricate workings is as it emerges as a beacon of hope in the realms of targeted compound transportation and immunotherapeutic compounds. Synonyms: LNFP VI; D-Glucose, O-β-D-galactopyranosyl-(1?4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-β-D-galactopyranosyl-(1?4)-O-[6-deoxy-α-L-galactopyranosyl-(1?3)]-; Gal-b-1,4-GlcNAc-b-1,3-Gal-b-1,4-[Fuc-a1,3]Glc. Grades: 95%. CAS No. 145876-86-4. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-hexaose | Lacto-N-hexaose is an esteemed and extensively employed compound with field assuming a pivotal position in the research of numerous afflictions such as gastrointestinal disorders and viral infections. By virtue of its distinctive structural composition, Lacto-N-hexaose showcases an unparalleled therapeutic capacity, thereby stimulating optimistic prospects for the creation of innovative pharmaceutical compounds intended to study these exigencies. Synonyms: LNH; LNThex; D-Glucose, O-beta-D-galactopyranosyl-(1-3)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-3)-O-(O-beta-D-galactopyranosyl-(1-4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-6))-O-beta-D-galactopyranosyl-(1-4)-; β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-(β-D-Gal-[1?4]-β-D-GlcNAc-[1?6])-β-D-Gal-(1?4)-D-Glc. Grades: ≥95%. CAS No. 64003-51-6. Molecular formula: C40H68N2O31. Mole weight: 1072.96. | |
| Lactonic (di-acetylated) Sophorolipids | Lactonic sophorolipid is a natural antimicrobial surfactant for oral hygiene. Lactonic sophorolipid, a potential anticancer agent, induces apoptosis in human HepG2 cells through the caspase-3 pathway. Uses: Widely used in oilfield field, environmental remediation field, agriculture, animal husbandry and aquaculture fields, daily chemicals, cleaning, personal care: it can replace chemical surfactants, with excellent surface performance, safety, biodegradability, strong detergency, low foam type and easy to rinse. Synonyms: 17-L-[(2'-O-β-D-Glucopyranosyl-β-D-glucopyranosyl)oxy]-cis-9-octadecenoic acid 1',4"-lactone 6',6"-diacetate. CAS No. 148409-20-5. Molecular formula: C34H56O14. Mole weight: 688.80. | |
| Lacto-N-neodifucohexaose | Lacto-N-neodifucohexaose is a remarkable and prodigious compound, unveiling its colossal potentiality in an extensive array of ailments' therapies. Profoundly deviating from the conventional medicine panorama, this extraordinary compound manifests its profound therapeutic proficiencies through the prophylaxis of bacterial invasions is amplification of the immune system's prowess and alleviation of inflammation. Emanating as an epitome of immunomodulation, it has exhibited compelling outcomes when studying selected malignancies and gastrointestinal disorders. Furthermore, Lacto-N-neodifucohexaose serves as an invaluable diagnostic apparatus, proficiently identifying peculiar pathogens alongside distinct markers linked to sundry diseases. Synonyms: Gal-b-1-4(Fuc-a-1-3)GlcNAc-b-1-3Gal-b-1-4(Fuc-a-1-3)Glc; Lewis X hexaose; LNnDH. Molecular formula: C38H65NO29. Mole weight: 999.93. | |
| Lacto-N-neodifucohexaose II | Lacto-N-neodifucohexaose II is a highly esteemed compound in the biomedical sector, emerging as an invaluable resource boasting promising proclivities for studying specified ailments and circumstances. Delving into its potential therapeutic aptitudes concerning distinct pharmacological targets and disorders necessitates unwavering dedication towards empirical scientific investigations and meticulous clinical experimentation. Any inquisitive souls yearning for a comprehensive grasp of its multifaceted utilities and inherent characteristics are urged to peruse the instructive web portals duly mentioned for comprehensive elucidation. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-neofucopentaose | Lacto-N-neofucopentaose is a compound product used for investigating the role of carbohydrates in various diseases. This compound can be utilized for studying the binding properties and interactions with lectin proteins is aiding in the research of cancer, inflammation and microbial infections. Synonyms: Gal-b-1-4-GlcNAc-b-1-3-Gal-b-1-4(Fuc-a-1-3)Glc. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-neohexaose | Lacto-N-neohexaose is a cutting-edge compound with remarkable anti-inflammatory powers, aiding in the research of autoimmune disorders, most notably rheumatoid arthritis. Synonyms: D-Glucose, O-β-D-galactopyranosyl-(1?4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-[O-β-D-galactopyranosyl-(1?4)-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?6)]-O-β-D-galactopyranosyl-(1?4)-; O-β-D-Galactopyranosyl-(1?4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-[O-β-D-galactopyranosyl-(1?4)-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?6)]-O-β-D-galactopyranosyl-(1?4)-D-glucose. Grades: ≥90%. CAS No. 64003-52-7. Molecular formula: C40H68N2O31. Mole weight: 1072.96. | |
| Lacto-N-neooctaose | Lacto-N-neooctaose is a biomedical product, emerging as a prebiotic and fomenting substantial research in gut health. Synonyms: Gal-b-1-4-GlcNAc-b-1-3-Gal-b-1-4-GlcNAc-b-1-3-Gal-b-1-4-GlcNAc-b-1-3-Gal-b-1-4-Glc; LNnO. Molecular formula: C54H91N3O41. Mole weight: 1438.30. | |
| Lacto-N-neotetraosa-APD-HSA | | |
| Lacto-N-neotetraose | Lacto-N-neotetraose is a valuable biomolecule predominantly utilized as a prebiotic supplement. Additionally, Lacto-N-neotetraose has shown potential in modulating the immune system, making it a promising candidate for the research of various autoimmune disorders. Synonyms: Gal-b-1,4-GlcNAc-b-1,3-Gal-b-1,4-Glc; LNnT; O-β-D-galactopyranosyl-(1?4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-β-D-galactopyranosyl-(1?4)-D-Glucose; N-Neotetraose; beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc; beta-D-galactosyl-(1->4)-beta-D-N-acetylglucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose. Grades: ≥95%. CAS No. 13007-32-4. Molecular formula: C26H45NO21. Mole weight: 707.63. | |
| Lacto-N-neotetraose-GEL | | |
| Lacto-N-tetraose | Lacto-N-tetraose is a fascinating carbohydrate compound, aiding in studying gastrointestinal disorders and specific cancer variants. Synonyms: Gal-b-1,3-GlcNAc-b-1,3-Gal-b-1,4-Glc; LNT; R-lactotetraose-HSA; Beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->3)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose; BetaD-Galp(1?3)betaD-GlcpNAc(1?3)betaD-Galp(1?4)D-Glcp; 4-O-[3-O-[3-O-beta-D-Galactopyranosyl-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-beta-D-galactopyranosyl]-D-glucopyranose. Grades: ≥90%. CAS No. 14116-68-8. Molecular formula: C26H45NO21. Mole weight: 707.63. | |
| Lacto-N-tetraose-a-APD-HSA | | |
| Lacto-N-tetraose-APD-KLH | Lacto-N-tetraose-APD-KLH is a fascinating biomedical compound, exhibiting profound immunostimulatory properties. This remarkable compound works tirelessly to instigate the generation of bespoke antibodies, specifically tailored to study recalcitrant pathogens or malignancies. | |
| Lacto-N-tetraose-BSA | | |
| Lacto-N-tetraose-GEL | Lacto-N-tetraose-GEL is a remarkable biomedical compound, unleashing its formidable antibacterial prowess. This unique gel formulation graciously diffuses its potency to effectively thwart Gram-positive and Gram-negative strains alike. | |
| Lacto-N-triose I | Lacto-N-triose I is an avant-garde compound, exhibiting significant potency in impeding bacterial adhesion. It can aid in studying infections instigated by uropathogenic Escherichia coli. Synonyms: O-b-D-Galactopyranosyl-(1?3)-O-2-(acetylamino)-2-deoxy-b-D-glucopyranosyl-(1?4)-D-galactose. CAS No. 19945-86-9. Molecular formula: C20H35NO16. Mole weight: 545.49. | |
| Lacto-N-triose II | Lacto-N-triose II is a profoundly sophisticated compound, vividly contributing to studying an assortment of afflictions, notably cancer, autoimmune disorders and neurological ailments. It has the unparalleled aptitude for pinpointing discrete cells and catalyzing targeted pharmaceutical transportation. Synonyms: D-Glucose, O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-β-D-galactopyranosyl-(1?4)-; O-2-(Acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-β-D-galactopyranosyl-(1?4)-D-glucose; Lacto-N-triaose; Agalacto-N-neotetraose. CAS No. 75645-27-1. Molecular formula: C20H35NO16. Mole weight: 545.49. | |
| Lactosazone | Lactosazone is an intermediate in the synthesis of Hydralazine Lactosone Ring-opened Adduct. Hydralazine Lactosone Ring-opened Adduct is a derivative of Lactose. Synonyms: 4-O-β-D-Galactopyranosyl-D-arabino-hexosulose Bis(phenylhydrazone); Lactose Phenylosazone; NSC 56106; 4-O-β-D-Galactopyranosyl-D-arabino-Hexos-2-ulose Bis(phenylhydrazone). Grades: 97%. CAS No. 4746-17-2. Molecular formula: C24H32N4O9. Mole weight: 520.53. | |
| Lactose 1-O-allyl | Lactose 1-O-allyl is a crucial compound playing a vital role in drug development by serving as a versatile building block for the synthesis of various pharmaceutical compounds. Its derivatives have shown potential in studying certain diseases such as diabetes, liver disorders and inflammation. Molecular formula: C15H26O11. Mole weight: 382.36. | |
| Lactose 3-sulfate | Lactose 3-sulfate is an esteemed compound of immense worth employed, astoundingly showcases profound efficacy in studying a myriad of afflictions, including cancer and inflammation. Synonyms: 4-O-(3-O-Sulfo-b-D-galactopyranosyl)-D-glucopyranose. CAS No. 159358-51-7. Molecular formula: C12H22O14S. Mole weight: 422.36. | |
| Lactose 6-sulfate | Lactose 6-sulfate is a notable disaccharide possessing a sulfate moiety, extensively employed in the realm of biomedical investigation. Significantly, it exhibits exceptional immunogenicity, qualifying as an invaluable probe for examining intricate carbohydrate-protein alliances and glycosaminoglycan biogenesis. Synonyms: Lactose 6'-sulfate; 1015758-24-3. CAS No. 1015758-24-3. Molecular formula: C12H22O14S. Mole weight: 422.36. | |
| Lactose - anhydrous | Cas No. 63-42-3. | |
| Lactose N-(Phthalazin-8-yl)-hydrazone | Lactose N-(Phthalazin-8-yl)-hydrazone is an intermediate in the synthesis of Hydralazine Lactosone Ring-opened Adduct. Hydralazine Lactosone Ring-opened Adduct is a derivative of Lactose. Synonyms: (E)-6-(2-(Phthalazin-1-yl)hydrazono)-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,4,5-tetraol. Grades: 95%. Molecular formula: C20H28N4O10. Mole weight: 484.46. | |
| Lactose octaacetate | Lactose octaacetate, an essential biomedical product, serves as a crucial excipient in drug formulations. Widely embraced in the pharmaceutical realm, it assumes a pivotal role as a tablet and capsule diluent, endowing superior drug stability and promoting efficient drug delivery. Additionally, Lactose octaacetate exhibits its versatility as a pharmaceutical adjuvant, benefiting the treatment of diverse ailments by augmenting drug solubility and optimizing bioavailability. Synonyms: Octa-O-acetyl-D-lactose; 4-O-(2,3,4,6-Tetra-O-acetyl-b-D-galactopyranosyl)-1,2,3,6-tetra-O-acetyl-D-glucopyranose; Peracetylated lactose; Lactose peracetyate. CAS No. 6291-42-5. Molecular formula: C28H38O19. Mole weight: 678.59. | |
| Lactose octaisobutyrate | Lactose octaisobutyrate is a paramount biomedical compound prevalent in the pharmaceutical realm, finding its foremost utilization in drug delivery systems. This multifaceted compound notably studys the solubility and stability of specific compounds, thereby augmenting their bioavailability. Molecular formula: C44H70O19. Mole weight: 903.02. | |
| Lactose oleate | Lactose oleate is a pharmacological compound, exhibiting exceptional promise in diverse medicinal applications. Widely embraced as an indispensable excipient, this compound product unveils its emulsifying prowess in an array of pharmaceutical formulations. CAS No. 85256-00-4. Molecular formula: C18H34O2·C12H22O11. Mole weight: 624.76. | |
| Lactose-PAA-biotin | | |
| Lactose-sp-biotin | Lactose-sp-biotin is a biotin-labeled lactose derivative serving as an affinity probe for studying the carbohydrate-protein interactions involved in lactose metabolism and related pathologies. With its high affinity and specific binding, Lactose-sp-biotin enables the study of lactose-related diseases, like lactose intolerance or galactosemia, contributing to a better understanding of these conditions. Molecular formula: C31H54N4O14S. Mole weight: 738.85. | |
| Lactosyl-b-1,1-N-octanoyl-L-threo-sphingosine | Lactosyl-b-1,1-N-octanoyl-L-threo-sphingosine is a synthetic glycosphingolipid (GSL) with nonnatural stereochemistry. It is a caveolar uptake inhibitor, which blocks SV40 virus infection. Synonyms: C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0); D-lactosyl-β1-1'-N-octanoyl-L-threo-sphingosine; C8-threo-LacCer. Grades: >99%. CAS No. 939036-94-9. Molecular formula: C38H71NO13. Mole weight: 749.97. | |
| Lactosylceramide | Lactosylceramide, a vital glycosphingolipid molecule, plays an essential role in cell signaling, cell migration, and apoptosis, and is intricately involved in regulating inflammation and immune responses. Synonyms: Ceramide b-lactoside; Ceramide dihexoside (CDH); b-D-Galactosyl-(1-4)-D-glucosylceramide; Lactosyl-N-acylsphingosine; LacCer. CAS No. 4682-48-8. | |
| Lactosyl fluoride | Lactosyl fluoride is an extensively employed compound in the realm of biomedical research, exhibiting its remarkable inhibitory potential towards distinct glycosidases and glycosyltransferases that play crucial roles in carbohydrate recognition and processing. This compound serves as an invaluable tool for investigating intricate glycosylation processes and unraveling their profound implications in various ailments, including cancer, diabetes and infectious diseases. Synonyms: alpha-lactosyl fluoride; L-1150; 4-O-|A-D-Galactopyranosyl-|A-D-glucopyranosyl fluoride; (2S,3R,4S,5R,6R)-2-(((2R,3S,4R,5R,6R)-6-Fluoro-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (2S,3R,4S,5R,6R)-2-[(2R,3S,4R,5R,6R)-6-fluoro-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol. CAS No. 7792-96-3. Molecular formula: C12H21FO10. Mole weight: 344.29. | |
| Lactosyl Maprotiline | Lactosyl Maprotiline is the lactose conjugate of Maprotiline, an antidepressant. Molecular formula: C32H43NO10. Mole weight: 601.68. | |
| Lactulose | Lactulose, a disaccharide composed of galactose and fructose, is a stimulator of health-promoting bacterium growth in the gastrointestinal tract, used to treat chronic constipation and hepatic encephalopathy. Uses: Gastrointestinal agents. Synonyms: 4-O-(b-D-Galactopyranosyl)-D-fructofuranose. Grades: >98%. CAS No. 4618-18-2. Molecular formula: C12H22O11. Mole weight: 342.3. | |
| Lactulose - liquid | Lactulose - liquid is a biomedical product commonly used for developing the stool softener and osmotic laxative. It can also be utilized to decrease serum ammonia levels aiding in studying hepatic encephalopathy disease. Molecular formula: C12H22O11. Mole weight: 342.3. | |
Our database is helping our users find suppliers everyday.
